You may agree or disagree but historical statistics on diabetes support that "genetic modifications" to biosynthetic human insulin analogues prove less effective at avoiding complications of diabetes than highly purified natural insulins from former years. In fact, human insulin analogues possibly catalyze the rate at which complications occur. Isn't the whole point of insulin to avoid complications of diabetes? So who's really winning here - the insulin industry or the captive consumer?

Anybody remember the research from 1983? Yeah, me neither. But thanks to modern technology and super powered databases - PubMed refreshed my memory with studies of days gone by. I'm sure the kingpins of the insulin cartel aren't as thankful for the fruits of the information superhighway - but I assure you I'm smitten as a kitten with it! Why you ask? It appears that information in 1983 (the BIRTH YEAR of biosynthetic human insulin) led a small group of researchers to the conclusion that using biosynthetic human insulin would catalyze the destruction of beta cells. Put on your science sunglasses - this study is blazing with jaw dropping evidence that Big Pharma wished we never knew. Genetically modified insulin is conveniently deliberately destroying beta-cell activity in type 1 & type 2 diabetes. Aren't you curious why the insulin analogue companies are pumping the gas to light the fire for doctors to treat people with Type 2 diabetes with insulin analogues as fast as they can?

The study published in the Lancet (January 22, 1983) is titled, "Effects of new insulins on insulin and C-peptide antibodies, insulin dose, and diabetic control."

The researchers concluded that the use of insulins which more closely resemble the human form do not necessarily produce better diabetic control.

Researchers concluded from this study that patient insulin protocol should be based on antibody response. They studied how the body recognizes biosynthetic human insulin as a "foreign protein" - and treats it as a "proteina non grata" (aka we don't want your stinkin' insulin analogues!) What the immune system wants - the immune system gets.

A study done 15 years later explained why the use of biosynthetic human insulin was not preferential for ALL people with diabetes. The Type 1 immune system didn't want its own insulin in the first place. What makes Big Pharma so sure that biosynthetic human insulin would be the best CHOICE for treatment? According to Stephen Hall, investigative writer, "Invisible Frontiers: The Race to Synthesize the Human Gene" - not a gosh darn thing but the all-mighty dollar!

As the little lady from the old Burger King Commercials would say, "Where's the beef?" I've got your beef right here, lady. That study I mentioned in the last paragraph confirms the allegation that the insulin, itself, is what provokes the autoimmune attack on the beta cells. What does this mean? Insulin-dependent diabetes is the blueprint for the cash cow of Big Pharma - insulin analogues! In 2006 the cumulative bank between Eli Lilly, Novo Nordisk and Sanofi Aventis was approximately $3.3 billion.

Fellow Type 1s - shouldn't we be demanding royalties for the industry capitalizing from our genetic misgivings?

If you have 7 minutes to spare - I blogged a post script on the above information on YouTube at: http://www.youtube.com/watch?v=cLBdkm_krcI